Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-24 @ 5:07 PM
NCT ID:
NCT00953550
Eligibility Criteria:
Inclusion Criteria:
* Elective surgical patients with a planned rapid sequence induction of anaesthesia.
* Informed consent.
* Legally competent.
* Be able to understand Danish and be able to read the given information in Danish.
* Females can only participate if they have reached menopause, have had hysterectomy performed, use a coil as birthcontrol, or if they are sterilized.
Exclusion Criteria:
* Presence of kidney disease, defined as S-creatinine \>0,200 mmol/L.
* Known lung or heart disease, defined as NYHA-class \>2 or CCS-class \>2.
* Known allergic reactions to Rocuronium, Suxamethon, Propofol or Sugammadex.
* Contraindications to Suxamethon. Including raised P-potassium (\>5,0 mmol/L), untreated glaucoma, neuromuscular disorders or disposition to malignant hyperthermia.
* Body mass index of \>35 kg/m2.
* Pregnant.
* Breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00953550
Study Brief:
Protocol Section:
NCT00953550